Aeglea BioTherapeutics, Inc. Business Finance Contracts & Agreements
44 Contracts & Agreements
- Exchange Agreements (1 contract)
- Investor Rights Agreements (2)
- Purchase Agreements (9)
- Registration Rights Agreements (8)
- Stock Agreements (14)
- Underwriting Agreements (6)
- Warrant Agreements (4)
- Underwriting Agreement, by and among the Company and (Filed With SEC on November 19, 2024)
- Form of Restricted Stock Unit Award Agreement under the Amended Spyre Therapeutics, Inc. 2018 Equity Inducement Plan (Filed With SEC on August 7, 2024)
- Form of Warrant to Purchase Common Stock (Parapyre Warrant 2023) (Filed With SEC on May 9, 2024)
- Exchange Agreement, dated April 23, 2024, by and between the Company and Fairmount Healthcare Fund II L.P (Filed With SEC on April 25, 2024)
- Form of Registration Rights Agreement (Filed With SEC on March 18, 2024)
- Securities Purchase Agreement, dated as of March 18, 2024, by and among Spyre Therapeutics, Inc. and each purchaser identified on Annex A thereto (Filed With SEC on March 18, 2024)
- Spyre Therapeutics, Inc. 2016 Employee Stock Purchase Plan, as amended by the First Amendment on January 31, 2024 (Filed With SEC on March 1, 2024)
- Asset Purchase Agreement, dated July 27, 2023, by and between the Company and Immedica Pharma AB (Filed With SEC on December 22, 2023)
- Form of Stock Restriction Agreement (Filed With SEC on December 22, 2023)
- Form of Stock Option Agreement under the Amended and Restated 2018 Equity Inducement Plan (Filed With SEC on December 22, 2023)
- 2016 Employee Stock Purchase Plan and forms of award agreements, as amended (Filed With SEC on December 22, 2023)
- Form of Registration Rights Agreement, by and among the Company and certain purchasers (June 2023 PIPE) (Filed With SEC on December 22, 2023)
- Securities Purchase Agreement, dated December 7, 2023, by and among Spyre Therapeutics, Inc. and each purchaser identified on Annex A thereto (Filed With SEC on December 22, 2023)
- Form of Common Stock Certificate (Filed With SEC on December 22, 2023)
- Form of Registration Rights Agreement (December 2023 PIPE) (Filed With SEC on December 22, 2023)
- Form of Registration Rights Agreement (Filed With SEC on December 8, 2023)
- Securities Purchase Agreement, dated as of December 7, 2023, by and among Spyre Therapeutics, Inc. and each purchaser identified on Annex A thereto (Filed With SEC on December 8, 2023)
- Asset Purchase Agreement, dated July 27, 2023, by and between Aeglea BioTherapeutics, Inc. and Immedica Pharma AB (Filed With SEC on November 15, 2023)
- Form of Stock Restriction Agreement (Filed With SEC on November 15, 2023)
- Form of Stock Option Agreement under the Aeglea BioTherapeutics, Inc. 2018 Equity Inducement Plan (Filed With SEC on November 15, 2023)
- 2016 Employee Stock Purchase Plan and forms of award agreements, as amended (Filed With SEC on November 15, 2023)
- Form of Registration Rights Agreement, by and among Aeglea BioTherapeutics, Inc. and certain purchasers (Filed With SEC on November 15, 2023)
- Registration Rights Agreement, dated March 16, 2021, by and among the Registrant and Baker Brothers Life Sciences, L.P. and 667, L.P (Filed With SEC on November 15, 2023)
- Form of Common Stock Certificate (Filed With SEC on November 15, 2023)
- Securities Purchase Agreement, dated June 22, 2023, by and among the Registrant and the purchasers named therein (Filed With SEC on November 15, 2023)
- Asset Purchase Agreement, dated July 27, 2023, by and between Aeglea BioTherapeutics, Inc. and Immedica Pharma AB (Filed With SEC on August 11, 2023)
- Form of Stock Option Agreement under the Aeglea BioTherapeutics, Inc. 2018 Equity Inducement Plan (Filed With SEC on August 11, 2023)
- Form of Registration Rights Agreement, by and among Aeglea BioTherapeutics, Inc. and certain purchasers (Filed With SEC on June 23, 2023)
- Securities Purchase Agreement, dated as of June 22, 2023, by and among Aeglea BioTherapeutics, Inc. and each purchaser identified on Annex A thereto (Filed With SEC on June 23, 2023)
- Form of Securities Purchase Agreement, dated as of May 5, 2022, by and among Aeglea BioTherapeutics, Inc. and the purchasers identified therein (Filed With SEC on May 6, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on May 6, 2022)
- Registration Rights Agreement, dated March 16, 2021, by and among the Registrant and Baker Brothers Life Sciences, L.P. and 667, L.P (Filed With SEC on March 18, 2021)
- Form of Pre-Funded Warrant (Filed With SEC on April 28, 2020)
- Underwriting Agreement dated April 28, 2020 (Filed With SEC on April 28, 2020)
- 2016 Employee Stock Purchase Plan and forms of award agreements, as amended (Filed With SEC on March 7, 2019)
- Amendment #1, dated December 4, 2018, to Amendment and Restated Investors' Rights Agreement, as amended (Filed With SEC on March 7, 2019)
- Form of Pre-Funded Warrant (Filed With SEC on February 7, 2019)
- Underwriting Agreement dated February 5, 2019, as amended (Filed With SEC on February 7, 2019)
- Underwriting Agreement dated April 18, 2018 (Filed With SEC on April 19, 2018)
- UNDERWRITING AGREEMENT 3,000,000Shares AEGLEA BIOTHERAPEUTICS, INC. Common Stock ($0.0001 Par Value) EQUITY UNDERWRITING AGREEMENT (Filed With SEC on June 6, 2017)
